• Join
  • Login
  • Contact

Search abstracts

The economics of stratified medicine

  • In: D8 - How patient stratification and pharmacogenetics affect ADRs in complex patients on Thursday, 5 September 2013, 14:00-17:00
  • At: Dublin (Ireland) (2013)
  • Type: Presentation
  • By: REDEKOP, Ken (Erasmus University, Institute for Medical Technology Assessment, Rotterdam, Netherlands)
  • Abstract:


    : Stratified medicine (SM) refers to the separation of a patient population into more homogeneous subgroups, with the overall aim of distinguishing between the patients likely to benefit from a treatment and the patients unlikely to benefit. SM can thereby increase the average treatment effectiveness (by filtering out non-responders) and


  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses